Trials / Completed
CompletedNCT04342507
Probiotics for Treatment of Chalazion in Adults
Effects of Probiotic Oral Supplementation on the Treatment of Chalazion in Adults: a Pilot Study on 20 Patients
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- University of Molise · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
There is growing evidence encouraging probiotics use in several diseases. The aim of the investigator's study is to define the possible beneficial impact of probiotics on adults suffering from chalazia.
Detailed description
Prospective comparative pilot study on 20 adults suffering from chalazion randomly divided into two groups. The first group, received conservative treatment with lid hygiene, warm compression, and dexamethasone/tobramycin ointment for at least 20 days. The second group, in addition to the conservative treatment, received a mixture of probiotic microorganisms once a day up to 3 months. Chalazia were classified according to their size into three groups: small (≤2 mm), medium (2-4 mm), or large (\>4 mm). When conservative treatment (with and without probiotics supplementation) failed to resolve the lesion, invasive methods were used, (intralesion steroid injection in medium size chalazion and surgical incision and curettage for the largest ones).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | conservative treatment | lid hygiene, warm compression, and dexamethasone/tobramycin ointment for at least 20 days. |
| DIETARY_SUPPLEMENT | probiotics | use specific probiotics in addiction to conservative treatment to modify the intestinal microbiome to ameliorate the clinical course of adults chalazia by re-establishing intestinal and immune homeostasis |
Timeline
- Start date
- 2019-02-01
- Primary completion
- 2020-02-29
- Completion
- 2020-02-29
- First posted
- 2020-04-13
- Last updated
- 2020-04-14
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT04342507. Inclusion in this directory is not an endorsement.